RECENT NEWS
SeekingAlpha  Sep 15  Comment 
By Christopher F. Davis: Response Genetics, Inc. (NASDAQ:RGDX) one of my favorite plays in the molecular diagnostics sector tests for cancer has just announced that it has launched a new and innovative Non-Small Cell Lung Cancer Profile that...
DailyFinance  Sep 15  Comment 
MELBOURNE, AUSTRALIA -- (Marketwired) -- 09/15/14 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") is pleased to announce plans for the restructure and realignment of group activities. These changes will enable the Company to...
DailyFinance  Apr 9  Comment 
TUCSON, AZ -- (Marketwired) -- 04/09/14 -- HTG Molecular Diagnostics, Inc., (HTG) today announced that Patrick Roche, Ph.D., has joined the company as Sr. Vice President for IVD Assay Development. Dr. Roche joins HTG from Ventana Medical...
DailyFinance  Apr 7  Comment 
TUCSON, AZ -- (Marketwired) -- 04/07/14 -- HTG Molecular Diagnostics, Inc., (HTG) and OvaGene Oncology have entered a manufacturing supply agreement where OvaGene will design and develop their proprietary gene expression assays on HTG's fully...
Wall Street Journal  Apr 7  Comment 
Roche said that it has acquired privately held IQuum to strengthen its molecular diagnostics business.
DailyFinance  Apr 4  Comment 
PORTLAND, OR and CAMBRIDGE, MA -- (Marketwired) -- 04/04/14 -- MolecularMD, Inc., a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial services for targeted cancer therapies, today...
SeekingAlpha  Mar 28  Comment 
By The Biggest Lilliputian: A small- to mid-cap biotech company with a 5-year CAGR of 22%, a P/E just over 15, no debt, and a 28% return on equity? Already, Myriad Genetics, Inc. (MYGN) sounds too good to be true. Is it? Glancing at the...
DailyFinance  Mar 21  Comment 
TUCSON, AZ -- (Marketwired) -- 03/21/14 -- HTG Molecular Diagnostics, Inc. (HTG) today announced that Lewis (Lew) Shuster has joined its board of directors. Mr. Shuster is CEO of Shuster Capital, a strategic and operating advisory firm to...
SeekingAlpha  Mar 7  Comment 
By Grant Zeng: Rosetta Genomics (ROSG) is an Israel-based molecular diagnostic company focused on developing and commercializing molecular diagnostics for cancers. Rosetta's diagnostic business is based on its unique and proprietary microRNA...
DailyFinance  Feb 26  Comment 
DUBLIN, IRELAND -- (Marketwired) -- 02/26/14 -- Research and Markets ( http://www.researchandmarkets.com/research/93trzd/molecular) has announced the addition of the "Molecular Diagnostics Markets" report to their offering. The...




 

Molecular diagnostics is a new method of detecting a disease by analyzing a patient's DNA

Companies in the Molecular Diagnostics Industry (4)

  • M
  • Company icon
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki